Rostec

Rostec is a Russian state-owned conglomerate with a significant presence in healthcare through subsidiaries that develop and manufacture vaccines—including mRNA-based vaccines—biosimilars, small molecule drugs, and a wide range of medical devices. Its pharmaceutical arm Nacimbio supplies key vaccines for Russia’s National Immunization Schedule. The company also builds advanced oncology centers featuring proton therapy. Recent projects include large-scale vaccine manufacturing partnerships using technology from global leaders like Serum Institute of India. Rostec’s health sector activities are commercialized nationwide with ongoing infrastructure expansion.